Richard Nolan Townsend, CEO: Lexeo Therapeutics LXEO Sell · Filed 25/10/17

Trade details

Type: Insider sale
Amount: $116,085.9
Shares · price: 12,985 sh · $8.94 a share
Held after: 242,266 sh
Stock: Lexeo Therapeutics LXEO
Person: Richard Nolan TownsendCEO
Trade date: 25/10/17
Filed: 25/10/17
Days to filing: 0 days

Sold 5.1% of holdings

Share of holding sold: 5.1%

Lexeo Therapeutics trades, last 26 weeks

What else happened in Lexeo Therapeutics around then

Filed or reported within 30 days of the trade day · 25/09/17~25/11/16

Richard Nolan Townsend's recent trades

Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.6K
3,345 sh
$16.6K
Filed 08/18
Traded 08/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$116.2K
25,947 sh
$116.2K
Filed 07/01
Traded 07/01
Richard Nolan TownsendCEO
SellLexeo Therapeutics
Sell
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/20
Traded 05/18
Richard Nolan TownsendCEO
Planned saleLexeo Therapeutics
Planned sale
Lexeo Therapeutics
LXEO
$16.9K
3,342 sh
$16.9K
Filed 05/18
Traded 05/18
Richard Nolan TownsendCEO
Sell10b5-1 planLexeo Therapeutics
Sell10b5-1 plan
Lexeo Therapeutics
LXEO
$313K
55,000 sh
$313K
Filed 04/07
Traded 04/06

Richard Nolan Townsend, CEO — sold $116.1K of Lexeo Therapeutics LXEO · 5.1% of holdings | Whalegun